This is an image preview.
Start a Free Account
to view the full image.

Nearly 3,000 illustrations, including video clips of neurologic disorders.
Every article is reviewed by our esteemed Editorial Board for accuracy and currency.
Full spectrum of neurology in 1,200 comprehensive articles.
Listen to MedLink on the go with Audio versions of each article.

D-2-hydroxyglutaric aciduria type I: clinically important pathways

Download

The enzyme hydroxyacid-oxoacid transhydrogenase (HOT) (B) oxidizes gamma-hydroxybutyric acid, a potentially toxic metabolite, to succinic semialdehyde, simultaneously reducing 2-ketoglutaric acid to D-2-OH glutaric acid. Accumulation of D-2-OH-glutaric acid due to this interconversion is normally balanced by D-2-hydroxyglutarate dehydrogenase (A). A block in A by D-2-hydroxyglutarate dehydrogenase deficiency shifts the equilibrium in B causing an accumulation of D-2-OH-glutaric acid as well as succinic semialdehyde. The latter in turn causes an increase in GABA. In D-2-hydroxyglutaric aciduria type II, there is no block at A, but accumulation of D-2-OH-glutaric acid arises from excess production due to a molecular change in mitochondrial isocitric dehydrogenase. (Adapted from: Struys EA, Verhoeven NM, Ten Brink HJ, et al. Kinetic characterization of human hydroxyacid-oxoacid transhydrogenase: relevance to D-2-hydroxyglutaric and gamma-hydroxybutyric acidurias. J Inherit Metab Dis 2005c;28(6):921-30.)